Microvascular decompression (MVD) is a proven effective method for treating trigeminal neuralgia. However, compression of the 7th and 8th cranial nerves by vascular structures during surgery can lead to variable outcomes in auditory function. This case report presents a rare case suggesting that progressive hearing loss in the right ear may be primarily due to compression of the 7th and 8th nerves. A 53-year-old male patient with a history of bilateral sensorineural hearing loss presented with progressive hearing loss in the right ear. Imaging and examination revealed a vascular structure compressing the 7th and 8th cranial nerves at the cerebellopontine angle. Therefore, MVD was performed on the right side. In the postoperative period, the patient reported a marked improvement in hearing in his right ear. However, audiological examinations performed in the first week and first month postoperatively revealed objective deterioration in pure tone thresholds and a predominance of the sensorineural component. This case demonstrates that compression of the 7th and 8th cranial nerves may play a critical role in progressive hearing loss. It also highlights the need to include tinnitus scales, speech intelligibility, and quality of life parameters in the assessment, not just pure-tone audiometry findings, after MVD.
Aim: Transforaminal epidural steroid injection (TFESI) is increasingly used for patients at high risk for invasive surgery. This study evaluated TFESI’s efficacy on functional recovery and examined how advanced age, comorbidities, and neutrophil-to-lymphocyte ratio (NLR) affect clinical outcomes.Material and Methods: This retrospective study included 100 patients with lumbar disc herniation, spinal stenosis, or foraminal narrowing who underwent unilateral TFESI. Oswestry Disability Index (ODI) and Numerical Pain Rating Scale (NPRS) scores were recorded before treatment and at 1, 3, and 6 months post-procedure. Patients were grouped by age (<65 and ≥65 years). Comorbidities, NLR, and pathology level (single/multilevel) were analyzed. Statistical tests used were Friedman, Wilcoxon with Bonferroni correction, Mann-Whitney U, and Kruskal-Wallis.Results: Significant functional improvement and pain reduction occurred early post-TFESI (p<0.001). Younger patients (<65 years) showed faster and greater improvement, while older patients (≥65 years) improved more slowly but significantly. Comorbidities did not significantly affect outcomes. Multilevel pathology and older age were linked to slower recovery. Patients with NLR ≥2.3 had significantly better ODI scores at 6 months (p=0.046).Conclusion: TFESI is a safe and effective treatment even for elderly patients, providing meaningful functional gains despite slower recovery. Multilevel degeneration and comorbidities may hinder recovery speed, whereas NLR could serve as a biological marker predicting treatment response. Beyond pain relief, TFESI aids surgical decision-making and personalized management in complex lumbar diseases.